APO Research

APO RESEARCH · REPORT

Drug Allergy Treatments and Drugs

Selected research

Market Analysis & Forecast

Global Drug Allergy Treatments and Drugs Market Analysis and Forecast 2026-2032

Market perspective

The global Drug Allergy Treatments and Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Drug Allergy Treatments and Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Allergy Treatments and Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Allergy Treatments and Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Allergy Treatments and Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Drug Allergy Treatments and Drugs include AAFA, Allergan plc, Allergy Therapeutics, Circassia, HAL Allergy Group, Mayo Clinic, Stallergenes Greer, Sunovion Pharmaceuticals and GlaxoSmithKline plc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Drug Allergy Treatments and Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Allergy Treatments and Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Drug Allergy Treatments and Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Allergy Treatments and Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Allergy Treatments and Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Drug Allergy Treatments and Drugs sales, projected growth trends, production technology, application and end-user industry.

Drug Allergy Treatments and Drugs Segment by Company

AAFA

Allergan plc

Allergy Therapeutics

Circassia

HAL Allergy Group

Mayo Clinic

Stallergenes Greer

Sunovion Pharmaceuticals

GlaxoSmithKline plc

Teva Pharmaceutical Industries

Drug Allergy Treatments and Drugs Segment by Type

Insulin

Penicillin and Related Drugs

Sulfa Drugs

Chemotherapy Drugs

Iodine

Other

Drug Allergy Treatments and Drugs Segment by Application

Pharmaceutical & Biotechnology Companies

Diagnostic Laboratories

Hospitals

Research & Academic Laboratories

Drug Allergy Treatments and Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Allergy Treatments and Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Allergy Treatments and Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Allergy Treatments and Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Drug Allergy Treatments and Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Drug Allergy Treatments and Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Allergy Treatments and Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Allergy Treatments and Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Insulin Major Manufacturers Table 3. Penicillin and Related Drugs Major Manufacturers Table 4. Sulfa Drugs Major Manufacturers Table 5. Chemotherapy Drugs Major Manufacturers Table 6. Iodine Major Manufacturers Table 7. Other Major Manufacturers Table 8. Global Drug Allergy Treatments and Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Pharmaceutical & Biotechnology Companies Major Manufacturers Table 10. Diagnostic Laboratories Major Manufacturers Table 11. Hospitals Major Manufacturers Table 12. Research & Academic Laboratories Major Manufacturers Table 13. Drug Allergy Treatments and Drugs Industry Trends Table 14. Drug Allergy Treatments and Drugs Industry Drivers Table 15. Drug Allergy Treatments and Drugs Industry Opportunities and Challenges Table 16. Drug Allergy Treatments and Drugs Industry Restraints Table 17. Global Drug Allergy Treatments and Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Drug Allergy Treatments and Drugs Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Drug Allergy Treatments and Drugs Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Drug Allergy Treatments and Drugs Revenue Market Share by Region (2021-2026) Table 21. Global Drug Allergy Treatments and Drugs Revenue Market Share by Region (2027-2032) Table 22. Global Drug Allergy Treatments and Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Drug Allergy Treatments and Drugs Sales by Region (2021-2026) & (K Units) Table 24. Global Drug Allergy Treatments and Drugs Sales by Region (2027-2032) & (K Units) Table 25. Global Drug Allergy Treatments and Drugs Sales Market Share by Region (2021-2026) Table 26. Global Drug Allergy Treatments and Drugs Sales Market Share by Region (2027-2032) Table 27. Global Drug Allergy Treatments and Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Drug Allergy Treatments and Drugs Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Drug Allergy Treatments and Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Drug Allergy Treatments and Drugs Sales Market Share by Manufacturers (2021-2026) Table 31. Global Drug Allergy Treatments and Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Drug Allergy Treatments and Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Drug Allergy Treatments and Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Drug Allergy Treatments and Drugs Manufacturers, Product Type & Application Table 35. Global Drug Allergy Treatments and Drugs Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Drug Allergy Treatments and Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Drug Allergy Treatments and Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Drug Allergy Treatments and Drugs Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Drug Allergy Treatments and Drugs Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Drug Allergy Treatments and Drugs Revenue Market Share by Type (2021-2026) Table 42. Global Drug Allergy Treatments and Drugs Revenue Market Share by Type (2027-2032) Table 43. Global Drug Allergy Treatments and Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 45. Global Drug Allergy Treatments and Drugs Sales by Type (2027-2032) & (K Units) Table 46. Global Drug Allergy Treatments and Drugs Sales Market Share by Type (2021-2026) Table 47. Global Drug Allergy Treatments and Drugs Sales Market Share by Type (2027-2032) Table 48. Global Drug Allergy Treatments and Drugs Price by Type (2021-2026) & (US$/Unit) Table 49. Global Drug Allergy Treatments and Drugs Price by Type (2027-2032) & (US$/Unit) Table 50. Global Drug Allergy Treatments and Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Drug Allergy Treatments and Drugs Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Drug Allergy Treatments and Drugs Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Drug Allergy Treatments and Drugs Revenue Market Share by Application (2021-2026) Table 54. Global Drug Allergy Treatments and Drugs Revenue Market Share by Application (2027-2032) Table 55. Global Drug Allergy Treatments and Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 57. Global Drug Allergy Treatments and Drugs Sales by Application (2027-2032) & (K Units) Table 58. Global Drug Allergy Treatments and Drugs Sales Market Share by Application (2021-2026) Table 59. Global Drug Allergy Treatments and Drugs Sales Market Share by Application (2027-2032) Table 60. Global Drug Allergy Treatments and Drugs Price by Application (2021-2026) & (US$/Unit) Table 61. Global Drug Allergy Treatments and Drugs Price by Application (2027-2032) & (US$/Unit) Table 62. AAFA Company Information Table 63. AAFA Business Overview Table 64. AAFA Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. AAFA Drug Allergy Treatments and Drugs Product Portfolio Table 66. AAFA Recent Development Table 67. Allergan plc Company Information Table 68. Allergan plc Business Overview Table 69. Allergan plc Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Allergan plc Drug Allergy Treatments and Drugs Product Portfolio Table 71. Allergan plc Recent Development Table 72. Allergy Therapeutics Company Information Table 73. Allergy Therapeutics Business Overview Table 74. Allergy Therapeutics Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Allergy Therapeutics Drug Allergy Treatments and Drugs Product Portfolio Table 76. Allergy Therapeutics Recent Development Table 77. Circassia Company Information Table 78. Circassia Business Overview Table 79. Circassia Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Circassia Drug Allergy Treatments and Drugs Product Portfolio Table 81. Circassia Recent Development Table 82. HAL Allergy Group Company Information Table 83. HAL Allergy Group Business Overview Table 84. HAL Allergy Group Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. HAL Allergy Group Drug Allergy Treatments and Drugs Product Portfolio Table 86. HAL Allergy Group Recent Development Table 87. Mayo Clinic Company Information Table 88. Mayo Clinic Business Overview Table 89. Mayo Clinic Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mayo Clinic Drug Allergy Treatments and Drugs Product Portfolio Table 91. Mayo Clinic Recent Development Table 92. Stallergenes Greer Company Information Table 93. Stallergenes Greer Business Overview Table 94. Stallergenes Greer Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Stallergenes Greer Drug Allergy Treatments and Drugs Product Portfolio Table 96. Stallergenes Greer Recent Development Table 97. Sunovion Pharmaceuticals Company Information Table 98. Sunovion Pharmaceuticals Business Overview Table 99. Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Product Portfolio Table 101. Sunovion Pharmaceuticals Recent Development Table 102. GlaxoSmithKline plc Company Information Table 103. GlaxoSmithKline plc Business Overview Table 104. GlaxoSmithKline plc Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. GlaxoSmithKline plc Drug Allergy Treatments and Drugs Product Portfolio Table 106. GlaxoSmithKline plc Recent Development Table 107. Teva Pharmaceutical Industries Company Information Table 108. Teva Pharmaceutical Industries Business Overview Table 109. Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Product Portfolio Table 111. Teva Pharmaceutical Industries Recent Development Table 112. North America Drug Allergy Treatments and Drugs Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Drug Allergy Treatments and Drugs Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 115. North America Drug Allergy Treatments and Drugs Sales by Type (2027-2032) & (K Units) Table 116. North America Drug Allergy Treatments and Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 117. North America Drug Allergy Treatments and Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 118. North America Drug Allergy Treatments and Drugs Revenue by Application (2021-2026) & (US$ Million) Table 119. North America Drug Allergy Treatments and Drugs Revenue by Application (2027-2032) & (US$ Million) Table 120. North America Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 121. North America Drug Allergy Treatments and Drugs Sales by Application (2027-2032) & (K Units) Table 122. North America Drug Allergy Treatments and Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 123. North America Drug Allergy Treatments and Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 124. North America Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. North America Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. North America Drug Allergy Treatments and Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 128. North America Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 129. North America Drug Allergy Treatments and Drugs Sales by Country (2027-2032) & (K Units) Table 130. North America Drug Allergy Treatments and Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 131. North America Drug Allergy Treatments and Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 132. United States Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 133. Canada Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 134. Mexico Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 135. Europe Drug Allergy Treatments and Drugs Revenue by Type (2021-2026) & (US$ Million) Table 136. Europe Drug Allergy Treatments and Drugs Revenue by Type (2027-2032) & (US$ Million) Table 137. Europe Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 138. Europe Drug Allergy Treatments and Drugs Sales by Type (2027-2032) & (K Units) Table 139. Europe Drug Allergy Treatments and Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 140. Europe Drug Allergy Treatments and Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 141. Europe Drug Allergy Treatments and Drugs Revenue by Application (2021-2026) & (US$ Million) Table 142. Europe Drug Allergy Treatments and Drugs Revenue by Application (2027-2032) & (US$ Million) Table 143. Europe Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 144. Europe Drug Allergy Treatments and Drugs Sales by Application (2027-2032) & (K Units) Table 145. Europe Drug Allergy Treatments and Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 146. Europe Drug Allergy Treatments and Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 147. Europe Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. Europe Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. Europe Drug Allergy Treatments and Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. Europe Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 152. Europe Drug Allergy Treatments and Drugs Sales by Country (2027-2032) & (K Units) Table 153. Europe Drug Allergy Treatments and Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 154. Europe Drug Allergy Treatments and Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 155. Germany Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 156. France Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 157. U.K. Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 158. Italy Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 159. Russia Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 160. Spain Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 161. Netherlands Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 162. Switzerland Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 163. Sweden Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 164. Poland Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 165. China Drug Allergy Treatments and Drugs Revenue by Type (2021-2026) & (US$ Million) Table 166. China Drug Allergy Treatments and Drugs Revenue by Type (2027-2032) & (US$ Million) Table 167. China Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 168. China Drug Allergy Treatments and Drugs Sales by Type (2027-2032) & (K Units) Table 169. China Drug Allergy Treatments and Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 170. China Drug Allergy Treatments and Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 171. China Drug Allergy Treatments and Drugs Revenue by Application (2021-2026) & (US$ Million) Table 172. China Drug Allergy Treatments and Drugs Revenue by Application (2027-2032) & (US$ Million) Table 173. China Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 174. China Drug Allergy Treatments and Drugs Sales by Application (2027-2032) & (K Units) Table 175. China Drug Allergy Treatments and Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 176. China Drug Allergy Treatments and Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Asia Drug Allergy Treatments and Drugs Revenue by Type (2021-2026) & (US$ Million) Table 178. Asia Drug Allergy Treatments and Drugs Revenue by Type (2027-2032) & (US$ Million) Table 179. Asia Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 180. Asia Drug Allergy Treatments and Drugs Sales by Type (2027-2032) & (K Units) Table 181. Asia Drug Allergy Treatments and Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 182. Asia Drug Allergy Treatments and Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 183. Asia Drug Allergy Treatments and Drugs Revenue by Application (2021-2026) & (US$ Million) Table 184. Asia Drug Allergy Treatments and Drugs Revenue by Application (2027-2032) & (US$ Million) Table 185. Asia Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 186. Asia Drug Allergy Treatments and Drugs Sales by Application (2027-2032) & (K Units) Table 187. Asia Drug Allergy Treatments and Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 188. Asia Drug Allergy Treatments and Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 189. Asia Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 190. Asia Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 191. Asia Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 192. Asia Drug Allergy Treatments and Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 193. Asia Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 194. Asia Drug Allergy Treatments and Drugs Sales by Country (2027-2032) & (K Units) Table 195. Asia Drug Allergy Treatments and Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 196. Asia Drug Allergy Treatments and Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 197. Japan Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 198. South Korea Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 199. India Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 200. Australia Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 201. Taiwan Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 202. Southeast Asia Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 203. SAMEA Drug Allergy Treatments and Drugs Revenue by Type (2021-2026) & (US$ Million) Table 204. SAMEA Drug Allergy Treatments and Drugs Revenue by Type (2027-2032) & (US$ Million) Table 205. SAMEA Drug Allergy Treatments and Drugs Sales by Type (2021-2026) & (K Units) Table 206. SAMEA Drug Allergy Treatments and Drugs Sales by Type (2027-2032) & (K Units) Table 207. SAMEA Drug Allergy Treatments and Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 208. SAMEA Drug Allergy Treatments and Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 209. SAMEA Drug Allergy Treatments and Drugs Revenue by Application (2021-2026) & (US$ Million) Table 210. SAMEA Drug Allergy Treatments and Drugs Revenue by Application (2027-2032) & (US$ Million) Table 211. SAMEA Drug Allergy Treatments and Drugs Sales by Application (2021-2026) & (K Units) Table 212. SAMEA Drug Allergy Treatments and Drugs Sales by Application (2027-2032) & (K Units) Table 213. SAMEA Drug Allergy Treatments and Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 214. SAMEA Drug Allergy Treatments and Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 215. SAMEA Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. SAMEA Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. SAMEA Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. SAMEA Drug Allergy Treatments and Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 219. SAMEA Drug Allergy Treatments and Drugs Sales by Country (2021-2026) & (K Units) Table 220. SAMEA Drug Allergy Treatments and Drugs Sales by Country (2027-2032) & (K Units) Table 221. SAMEA Drug Allergy Treatments and Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 222. SAMEA Drug Allergy Treatments and Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 223. Brazil Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 224. Argentina Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 225. Chile Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 226. Colombia Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 227. Peru Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 228. Saudi Arabia Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 229. Israel Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 230. UAE Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 231. Turkey Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 232. Iran Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 233. Egypt Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Drug Allergy Treatments and Drugs Distributors List Table 237. Drug Allergy Treatments and Drugs Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Drug Allergy Treatments and Drugs Image Figure 2. Global Drug Allergy Treatments and Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Allergy Treatments and Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Insulin Image Figure 5. Penicillin and Related Drugs Image Figure 6. Sulfa Drugs Image Figure 7. Chemotherapy Drugs Image Figure 8. Iodine Image Figure 9. Other Image Figure 10. Global Drug Allergy Treatments and Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Drug Allergy Treatments and Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 12. Pharmaceutical & Biotechnology Companies Image Figure 13. Diagnostic Laboratories Image Figure 14. Hospitals Image Figure 15. Research & Academic Laboratories Image Figure 16. Global Drug Allergy Treatments and Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Drug Allergy Treatments and Drugs Revenue (2021-2032) & (US$ Million) Figure 18. Global Drug Allergy Treatments and Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Drug Allergy Treatments and Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Drug Allergy Treatments and Drugs Revenue Market Share by Region (2021-2032) Figure 21. Global Drug Allergy Treatments and Drugs Sales (2021-2032) & (K Units) Figure 22. Global Drug Allergy Treatments and Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Drug Allergy Treatments and Drugs Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Drug Allergy Treatments and Drugs Sales YoY (2021-2032) & (K Units) Figure 25. Europe Drug Allergy Treatments and Drugs Sales YoY (2021-2032) & (K Units) Figure 26. China Drug Allergy Treatments and Drugs Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Drug Allergy Treatments and Drugs Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Drug Allergy Treatments and Drugs Sales YoY (2021-2032) & (K Units) Figure 29. Global Drug Allergy Treatments and Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Drug Allergy Treatments and Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Drug Allergy Treatments and Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Drug Allergy Treatments and Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Drug Allergy Treatments and Drugs Revenue Market Share by Type (2021-2032) Figure 35. Global Drug Allergy Treatments and Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Drug Allergy Treatments and Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Drug Allergy Treatments and Drugs Sales Market Share by Type (2021-2032) Figure 38. Global Drug Allergy Treatments and Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Drug Allergy Treatments and Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Drug Allergy Treatments and Drugs Revenue Market Share by Application (2021-2032) Figure 41. Global Drug Allergy Treatments and Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Drug Allergy Treatments and Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Drug Allergy Treatments and Drugs Sales Market Share by Application (2021-2032) Figure 44. North America Drug Allergy Treatments and Drugs Revenue Share by Type (2021-2032) Figure 45. North America Drug Allergy Treatments and Drugs Sales Share by Type (2021-2032) Figure 46. North America Drug Allergy Treatments and Drugs Revenue Share by Application (2021-2032) Figure 47. North America Drug Allergy Treatments and Drugs Sales Share by Application (2021-2032) Figure 48. North America Drug Allergy Treatments and Drugs Revenue Share by Country (2021-2032) Figure 49. North America Drug Allergy Treatments and Drugs Sales Share by Country (2021-2032) Figure 50. Europe Drug Allergy Treatments and Drugs Revenue Share by Type (2021-2032) Figure 51. Europe Drug Allergy Treatments and Drugs Sales Share by Type (2021-2032) Figure 52. Europe Drug Allergy Treatments and Drugs Revenue Share by Application (2021-2032) Figure 53. Europe Drug Allergy Treatments and Drugs Sales Share by Application (2021-2032) Figure 54. Europe Drug Allergy Treatments and Drugs Revenue Share by Country (2021-2032) Figure 55. Europe Drug Allergy Treatments and Drugs Sales Share by Country (2021-2032) Figure 56. China Drug Allergy Treatments and Drugs Revenue Share by Type (2021-2032) Figure 57. China Drug Allergy Treatments and Drugs Sales Share by Type (2021-2032) Figure 58. China Drug Allergy Treatments and Drugs Revenue Share by Application (2021-2032) Figure 59. China Drug Allergy Treatments and Drugs Sales Share by Application (2021-2032) Figure 60. Asia Drug Allergy Treatments and Drugs Revenue Share by Type (2021-2032) Figure 61. Asia Drug Allergy Treatments and Drugs Sales Share by Type (2021-2032) Figure 62. Asia Drug Allergy Treatments and Drugs Revenue Share by Application (2021-2032) Figure 63. Asia Drug Allergy Treatments and Drugs Sales Share by Application (2021-2032) Figure 64. Asia Drug Allergy Treatments and Drugs Revenue Share by Country (2021-2032) Figure 65. Asia Drug Allergy Treatments and Drugs Sales Share by Country (2021-2032) Figure 66. SAMEA Drug Allergy Treatments and Drugs Revenue Share by Type (2021-2032) Figure 67. SAMEA Drug Allergy Treatments and Drugs Sales Share by Type (2021-2032) Figure 68. SAMEA Drug Allergy Treatments and Drugs Revenue Share by Application (2021-2032) Figure 69. SAMEA Drug Allergy Treatments and Drugs Sales Share by Application (2021-2032) Figure 70. SAMEA Drug Allergy Treatments and Drugs Revenue Share by Country (2021-2032) Figure 71. SAMEA Drug Allergy Treatments and Drugs Sales Share by Country (2021-2032) Figure 72. Drug Allergy Treatments and Drugs Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Drug Allergy Treatments and Drugs Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin
  • Penicillin and Related Drugs
  • Sulfa Drugs
  • Chemotherapy Drugs
  • Iodine
  • Other
Applications
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Hospitals
  • Research & Academic Laboratories
Companies covered
  • AAFA
  • Allergan plc
  • Allergy Therapeutics
  • Circassia
  • HAL Allergy Group
  • Mayo Clinic
  • Stallergenes Greer
  • Sunovion Pharmaceuticals
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Allergy Treatments and Drugs Market by Type
  3. 1.2.1 Global Drug Allergy Treatments and Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Insulin
  5. 1.2.3 Penicillin and Related Drugs
  6. 1.2.4 Sulfa Drugs
  7. 1.2.5 Chemotherapy Drugs
  8. 1.2.6 Iodine
  9. 1.2.7 Other
  10. 1.3 Drug Allergy Treatments and Drugs Market by Application
  11. 1.3.1 Global Drug Allergy Treatments and Drugs Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Pharmaceutical & Biotechnology Companies
  13. 1.3.3 Diagnostic Laboratories
  14. 1.3.4 Hospitals
  15. 1.3.5 Research & Academic Laboratories
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Drug Allergy Treatments and Drugs Market Dynamics
  1. 2.1 Drug Allergy Treatments and Drugs Industry Trends
  2. 2.2 Drug Allergy Treatments and Drugs Industry Drivers
  3. 2.3 Drug Allergy Treatments and Drugs Industry Opportunities and Challenges
  4. 2.4 Drug Allergy Treatments and Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Drug Allergy Treatments and Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Drug Allergy Treatments and Drugs Revenue by Region
  3. 3.2.1 Global Drug Allergy Treatments and Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Allergy Treatments and Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Drug Allergy Treatments and Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Drug Allergy Treatments and Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Drug Allergy Treatments and Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Drug Allergy Treatments and Drugs Sales by Region
  9. 3.4.1 Global Drug Allergy Treatments and Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Drug Allergy Treatments and Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Drug Allergy Treatments and Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Drug Allergy Treatments and Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Drug Allergy Treatments and Drugs Revenue by Manufacturers
  2. 4.1.1 Global Drug Allergy Treatments and Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Drug Allergy Treatments and Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Drug Allergy Treatments and Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Allergy Treatments and Drugs Sales by Manufacturers
  6. 4.2.1 Global Drug Allergy Treatments and Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Drug Allergy Treatments and Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Drug Allergy Treatments and Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Drug Allergy Treatments and Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Drug Allergy Treatments and Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Drug Allergy Treatments and Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Drug Allergy Treatments and Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Drug Allergy Treatments and Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Drug Allergy Treatments and Drugs Market CR5 and HHI
  16. 4.8.2 2025 Drug Allergy Treatments and Drugs Tier 1, Tier 2, and Tier 3
5 Drug Allergy Treatments and Drugs Market by Type
  1. 5.1 Global Drug Allergy Treatments and Drugs Revenue by Type
  2. 5.1.1 Global Drug Allergy Treatments and Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Drug Allergy Treatments and Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Drug Allergy Treatments and Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Drug Allergy Treatments and Drugs Sales by Type
  6. 5.2.1 Global Drug Allergy Treatments and Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drug Allergy Treatments and Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Drug Allergy Treatments and Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Drug Allergy Treatments and Drugs Price by Type
6 Drug Allergy Treatments and Drugs Market by Application
  1. 6.1 Global Drug Allergy Treatments and Drugs Revenue by Application
  2. 6.1.1 Global Drug Allergy Treatments and Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Drug Allergy Treatments and Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Drug Allergy Treatments and Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Drug Allergy Treatments and Drugs Sales by Application
  6. 6.2.1 Global Drug Allergy Treatments and Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Drug Allergy Treatments and Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Drug Allergy Treatments and Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Drug Allergy Treatments and Drugs Price by Application
7 Company Profiles
  1. 7.1 AAFA
  2. 7.1.1 AAFA Company Information
  3. 7.1.2 AAFA Business Overview
  4. 7.1.3 AAFA Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AAFA Drug Allergy Treatments and Drugs Product Portfolio
  6. 7.1.5 AAFA Recent Developments
  7. 7.2 Allergan plc
  8. 7.2.1 Allergan plc Company Information
  9. 7.2.2 Allergan plc Business Overview
  10. 7.2.3 Allergan plc Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Allergan plc Drug Allergy Treatments and Drugs Product Portfolio
  12. 7.2.5 Allergan plc Recent Developments
  13. 7.3 Allergy Therapeutics
  14. 7.3.1 Allergy Therapeutics Company Information
  15. 7.3.2 Allergy Therapeutics Business Overview
  16. 7.3.3 Allergy Therapeutics Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Allergy Therapeutics Drug Allergy Treatments and Drugs Product Portfolio
  18. 7.3.5 Allergy Therapeutics Recent Developments
  19. 7.4 Circassia
  20. 7.4.1 Circassia Company Information
  21. 7.4.2 Circassia Business Overview
  22. 7.4.3 Circassia Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Circassia Drug Allergy Treatments and Drugs Product Portfolio
  24. 7.4.5 Circassia Recent Developments
  25. 7.5 HAL Allergy Group
  26. 7.5.1 HAL Allergy Group Company Information
  27. 7.5.2 HAL Allergy Group Business Overview
  28. 7.5.3 HAL Allergy Group Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 HAL Allergy Group Drug Allergy Treatments and Drugs Product Portfolio
  30. 7.5.5 HAL Allergy Group Recent Developments
  31. 7.6 Mayo Clinic
  32. 7.6.1 Mayo Clinic Company Information
  33. 7.6.2 Mayo Clinic Business Overview
  34. 7.6.3 Mayo Clinic Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mayo Clinic Drug Allergy Treatments and Drugs Product Portfolio
  36. 7.6.5 Mayo Clinic Recent Developments
  37. 7.7 Stallergenes Greer
  38. 7.7.1 Stallergenes Greer Company Information
  39. 7.7.2 Stallergenes Greer Business Overview
  40. 7.7.3 Stallergenes Greer Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Stallergenes Greer Drug Allergy Treatments and Drugs Product Portfolio
  42. 7.7.5 Stallergenes Greer Recent Developments
  43. 7.8 Sunovion Pharmaceuticals
  44. 7.8.1 Sunovion Pharmaceuticals Company Information
  45. 7.8.2 Sunovion Pharmaceuticals Business Overview
  46. 7.8.3 Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Sunovion Pharmaceuticals Drug Allergy Treatments and Drugs Product Portfolio
  48. 7.8.5 Sunovion Pharmaceuticals Recent Developments
  49. 7.9 GlaxoSmithKline plc
  50. 7.9.1 GlaxoSmithKline plc Company Information
  51. 7.9.2 GlaxoSmithKline plc Business Overview
  52. 7.9.3 GlaxoSmithKline plc Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 GlaxoSmithKline plc Drug Allergy Treatments and Drugs Product Portfolio
  54. 7.9.5 GlaxoSmithKline plc Recent Developments
  55. 7.10 Teva Pharmaceutical Industries
  56. 7.10.1 Teva Pharmaceutical Industries Company Information
  57. 7.10.2 Teva Pharmaceutical Industries Business Overview
  58. 7.10.3 Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Teva Pharmaceutical Industries Drug Allergy Treatments and Drugs Product Portfolio
  60. 7.10.5 Teva Pharmaceutical Industries Recent Developments
8 North America
  1. 8.1 North America Drug Allergy Treatments and Drugs Market Size by Type
  2. 8.1.1 North America Drug Allergy Treatments and Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Drug Allergy Treatments and Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Drug Allergy Treatments and Drugs Price by Type (2021-2032)
  5. 8.2 North America Drug Allergy Treatments and Drugs Market Size by Application
  6. 8.2.1 North America Drug Allergy Treatments and Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Drug Allergy Treatments and Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Drug Allergy Treatments and Drugs Price by Application (2021-2032)
  9. 8.3 North America Drug Allergy Treatments and Drugs Market Size by Country
  10. 8.3.1 North America Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Drug Allergy Treatments and Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Drug Allergy Treatments and Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Drug Allergy Treatments and Drugs Market Size by Type
  2. 9.1.1 Europe Drug Allergy Treatments and Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Drug Allergy Treatments and Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Drug Allergy Treatments and Drugs Price by Type (2021-2032)
  5. 9.2 Europe Drug Allergy Treatments and Drugs Market Size by Application
  6. 9.2.1 Europe Drug Allergy Treatments and Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Drug Allergy Treatments and Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Drug Allergy Treatments and Drugs Price by Application (2021-2032)
  9. 9.3 Europe Drug Allergy Treatments and Drugs Market Size by Country
  10. 9.3.1 Europe Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Drug Allergy Treatments and Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Drug Allergy Treatments and Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Drug Allergy Treatments and Drugs Market Size by Type
  2. 10.1.1 China Drug Allergy Treatments and Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Drug Allergy Treatments and Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Drug Allergy Treatments and Drugs Price by Type (2021-2032)
  5. 10.2 China Drug Allergy Treatments and Drugs Market Size by Application
  6. 10.2.1 China Drug Allergy Treatments and Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Drug Allergy Treatments and Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Drug Allergy Treatments and Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Allergy Treatments and Drugs Market Size by Type
  2. 11.1.1 Asia Drug Allergy Treatments and Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Drug Allergy Treatments and Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Drug Allergy Treatments and Drugs Price by Type (2021-2032)
  5. 11.2 Asia Drug Allergy Treatments and Drugs Market Size by Application
  6. 11.2.1 Asia Drug Allergy Treatments and Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Drug Allergy Treatments and Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Drug Allergy Treatments and Drugs Price by Application (2021-2032)
  9. 11.3 Asia Drug Allergy Treatments and Drugs Market Size by Country
  10. 11.3.1 Asia Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Drug Allergy Treatments and Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Drug Allergy Treatments and Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Allergy Treatments and Drugs Market Size by Type
  2. 12.1.1 SAMEA Drug Allergy Treatments and Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Drug Allergy Treatments and Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Drug Allergy Treatments and Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Drug Allergy Treatments and Drugs Market Size by Application
  6. 12.2.1 SAMEA Drug Allergy Treatments and Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Drug Allergy Treatments and Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Drug Allergy Treatments and Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Drug Allergy Treatments and Drugs Market Size by Country
  10. 12.3.1 SAMEA Drug Allergy Treatments and Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Drug Allergy Treatments and Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Drug Allergy Treatments and Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Drug Allergy Treatments and Drugs Value Chain Analysis
  2. 13.1.1 Drug Allergy Treatments and Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Drug Allergy Treatments and Drugs Production Mode & Process
  6. 13.2 Drug Allergy Treatments and Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Drug Allergy Treatments and Drugs Distributors
  9. 13.2.3 Drug Allergy Treatments and Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research